Pharmacokinetics | WELTRUZA™ (olanzapine) extended-release injectable suspension

WELTRUZA^™ is a [new] once-monthly subcutaneous long-acting injectable formulation of olanzapine.¹

Pharmacokinetics: Simulated Steady-State Plasma Concentration^2,3

Simulated Plasma Concentration Over Time in Patient Populations Treated with WELTRUZA and Oral Olanzapine During the First Day of Treatment²

WELTRUZA reaches levels comparable with oral olanzapine on first day of treatment.²

Simulated Steady-State Plasma Concentration–Time Profiles for WELTRUZA Versus Corresponding Oral Olanzapine Doses³

up next

Candidate patients

See how WELTRUZA may meet the needs of patients who respond well to olanzapine.

EXPLORE PATIENT TYPES

References: 1. WELTRUZA™ (olanzapine) extended-release injectable suspension Current Prescribing Information. Parsippany, NJ: Teva Neuroscience, Inc. 2. Data on file. Summary of Clinical Pharmacology Studies. June 2026. Parsippany, NJ: Teva Neuroscience, Inc. 3. Patel N, Schmidt H, Perlstein I, Merenlender-Wagner A, Elgart A, Singh R. Joint population pharmacokinetic model of olanzapine following oral, intramuscular, and subcutaneous (TV-44749) administration to support TV-44749 dose recommendations and switching strategies. Presented at: Schizophrenia International Research Society (SIRS) 2025 Annual Congress; March 25-March 29, 2026; Florence, Italy.

Important Safety
Information &
Indication

Indication

[Product Name] is indicated for the treatment of [condition/indication]. Please see full prescribing information for complete details on the proper use of this medication.

Contraindications

[Product Name] should not be used in patients who:

[Contraindication 1]
[Contraindication 2]
[Contraindication 3]

Warnings and Precautions

Use caution in patients with [condition].
[Product Name] may cause [adverse effect].
Discontinue use if [specific adverse event] occurs.

Potential Side Effects

The most common side effects observed include:

[Side effect 1]
[Side effect 2]
[Side effect 3]

Drug Interactions

[Product Name] may interact with [Drug A, Drug B, etc.]. Inform your healthcare provider of all medications you are taking.

Please consult your healthcare provider to determine if [Product Name] is right for you.

For full prescribing information, [insert hyperlink to the prescribing information document or PDF].

CODE-0000-0000

Are you a healthcare professional?

You are about to leave this site